Navigation Links
Genstar Names Michael Hurt to Its Strategic Advisory Board
Date:9/5/2007

CEO of Former Portfolio Company is a Proven Leader at Driving Growth

SAN FRANCISCO, Sept. 5 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences and healthcare services, industrial technology, business services and software, today announced the appointment of Michael L. Hurt to the firm's Strategic Advisory Board (SAB). The addition of Mr. Hurt, CEO of Altra Industrial Motion (Nasdaq: AIMC), a former Genstar portfolio company, increases to 18 the number of influential senior executives who are current or former leaders of major corporations and have joined the firm in this advisory capacity.

"I have known Mike for more than 15 years since my first LBO of the company he ran and he is a multi-talented executive who repeatedly has driven growth at the businesses he has overseen," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "The Genstar team has become familiar with Mike's ability to successfully lead organizations, most recently as head of our portfolio company Altra Holdings where he achieved spectacular growth and tripled operating profit in less than three years. We are very pleased that he will now provide the skills he has obtained over nearly 40 years of working with industrial technology businesses to our management teams as we grow our investments."

Mr. Hurt is currently CEO of Altra Industrial Motion, which designs, produces, and distributes a wide range of mechanical power transmission products that serve a variety of applications. Prior to leading Altra, he worked with Genstar as an advisor in the Industrial Technology area after retiring as the President and CEO of TB Wood's Corporation in November 2003. In addition to Altra, Mr. Hurt spent thirteen years at TB Wood's and 23 years with the Torrington Company, a division of Ingersoll Rand.

A graduate of Clemson University with a BSME degree in mechanical engineering, Mr. Hurt holds an MBA degree from Clemson-Furman University. He is a registered professional engineer.

The Genstar SAB includes executives from such leading companies as Pharmacia & Upjohn, Inc., CNA Insurance Companies, ITT Corporation, Deere & Co., Axia Health Management, MedImmune, Inc., Wild Oats Markets, WellPoint, Inc., NEN Life Science Products, and ICOS Corporation.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital (http://www.gencap.com) is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life science and healthcare services, industrial technology, business services and software services.


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... IPSWICH, Mass. , Feb. 17, 2017 /PRNewswire/ ... a small tumor had a mutation-conferring resistance to ... treatment. Recently, genomics research has focused on finding ... — or even from circulating tumor DNA in ... identify new oncology therapeutics. Unfortunately, however, ...
(Date:2/16/2017)... Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power ... triple negative breast cancer (TNBC), announced today their completion of ... The YEi Start in France ... their business in France and Europe.  ... complete an intensive one week immersion in France ...
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology:
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, ... on emerging technology, announces the availability of a new report, ... Continue Reading ... ... industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
Breaking Biology News(10 mins):